Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Botti

Showing results (151-160 of 153) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 153 results.
In Vivo (Athens, Greece)|May 6, 2009
Hyperthermic isolated perfusion with tumor necrosis factor-alpha and doxorubicin for the treatment of limb-threatening soft tissue sarcoma: the experience of the Italian Society of Integrated Locoregional Treatment in Oncology (SITILO)F Di Filippo, P Giacomini, C R Rossi, et al.
In Vivo (Athens, Greece)|May 6, 2009
Prognostic factors influencing tumor response, locoregional control and survival, in melanoma patients with multiple limb in-transit metastases treated with TNFalpha-based isolated limb perfusionF Di Filippo, P Giacomini, C R Rossi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 22, 2011
Fasting glucose and treatment outcome in breast and colorectal cancer patients treated with targeted agents: results from a historic cohortM Barba, F Sperati, S Stranges, et al.
Pageof 16

Showing results (151-160 of 153) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 153 results.
In Vivo (Athens, Greece)|May 6, 2009
Hyperthermic isolated perfusion with tumor necrosis factor-alpha and doxorubicin for the treatment of limb-threatening soft tissue sarcoma: the experience of the Italian Society of Integrated Locoregional Treatment in Oncology (SITILO)F Di Filippo, P Giacomini, C R Rossi, et al.
In Vivo (Athens, Greece)|May 6, 2009
Prognostic factors influencing tumor response, locoregional control and survival, in melanoma patients with multiple limb in-transit metastases treated with TNFalpha-based isolated limb perfusionF Di Filippo, P Giacomini, C R Rossi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 22, 2011
Fasting glucose and treatment outcome in breast and colorectal cancer patients treated with targeted agents: results from a historic cohortM Barba, F Sperati, S Stranges, et al.
Pageof 16